DocGo (NASDAQ:DCGO – Free Report) had its price target lowered by Needham & Company LLC from $7.00 to $4.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.
DocGo Stock Down 21.2 %
Shares of NASDAQ DCGO opened at $3.09 on Friday. The firm’s 50-day moving average price is $4.61 and its two-hundred day moving average price is $4.02. DocGo has a 52-week low of $2.75 and a 52-week high of $5.68. The stock has a market capitalization of $315.34 million, a P/E ratio of 11.04, a P/E/G ratio of 14.16 and a beta of 1.00.
Insider Buying and Selling
In related news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by company insiders.
Institutional Trading of DocGo
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Articles
- Five stocks we like better than DocGo
- What is the Nasdaq? Complete Overview with History
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How Investors Can Find the Best Cheap Dividend Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- Why Are Stock Sectors Important to Successful Investing?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.